ArticleFrontiers in medicine2026
Benchmarking five large language models in medical genetics: a bilingual comparative evaluation using published and novel expert-authored questions.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study asked whether five contemporary large language models answer medical genetics multiple-choice questions with equivalent accuracy on published versus novel items and across English and Turkish, and sought to characterize the errors that persist. Five models (GPT-5.2, Gemini 3 Pro, Claude Sonnet 4.6, Grok 4, and DeepSeek-V3.2) answered 100 four-option questions (50 from a published board review; 50 novel, expert-authored items absent from any database) in English and Turkish, yielding 1,000 responses. Correctness was modeled with item-clustered generalized estimating equation and Bayesian mixed-effects logistic regression (the latter as a prespecified sensitivity analysis); question provenance and language were tested for equivalence (item-clustered two one-sided tests, ±5-percentage-point margin), and the paired language effect with the McNemar test. Inter-model agreement and error concordance were examined. Overall accuracy was 97.7%. In the item-clustered GEE, only Gemini 3 Pro nominally exceeded the lowest-performing model; this imprecise contrast did not remain significant after Holm correction for the four secondary model comparisons, whereas the Bayesian sensitivity analysis additionally yielded a credible interval excluding 1 for GPT-5.2 versus Grok 4. Accuracy was statistically equivalent within the prespecified margin for published versus novel items (difference, -1.4 percentage points; item-clustered 90% CI, -4.1 to +1.3; item-clustered TOST
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.